Congress Takes Aim at Biostimulant Regulation

A bipartisan bill and $700M federal program are pushing U.S. biological crop inputs toward clearer regulatory ground

13 Dec 2025

For years, the U.S. biological crop inputs sector has operated in regulatory limbo. There's no federal definition of plant biostimulants, no clear path to market, and a patchwork of state rules that companies navigate at their own risk. Congress is trying to fix that, and this time it has a major federal spending initiative running alongside it.

Lawmakers in both chambers have introduced the Plant Biostimulant Act of 2025, a bipartisan bill that would amend the Federal Insecticide, Fungicide, and Rodenticide Act to establish a uniform federal definition for the category. Crucially, it would clarify that qualifying biostimulants fall outside FIFRA's plant-regulator classification, which has long been the source of legal ambiguity. The EPA would be directed to update its Code of Federal Regulations accordingly, and the USDA would be required to study biostimulants' contributions to soil health, carbon sequestration, and water quality.

The bill's sponsors span the aisle: Senators Roger Marshall and Alex Padilla in the Senate, Representatives Jim Baird and Jimmy Panetta in the House. The Biological Products Industry Alliance, among other groups, has publicly backed the measure, calling it essential for driving investment and shoring up U.S. competitiveness in agricultural biologicals.

The legislative push isn't happening in isolation. In December 2025, the USDA launched a $700 million Regenerative Pilot Program through its Natural Resources Conservation Service, splitting the funding between the Environmental Quality Incentives Program and the Conservation Stewardship Program. The initiative centers on soil health and whole-farm conservation planning, a focus that naturally favors the biopesticides and biostimulants central to regenerative agriculture.

Still, the bill faces real headwinds. Similar measures introduced in 2022, 2023, and as a Farm Bill amendment in 2024 all died in committee. The EPA hasn't finalized its 2020 draft guidance on biostimulant classification either, leaving the sector in the same fragmented holding pattern it has occupied for years.

The combination of bipartisan support and significant federal conservation dollars suggests the policy environment is shifting. Whether that momentum translates into law is another matter entirely.